Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SOTATERCEPT-CSRK for Pulmonary arterial hypertension: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 595 adverse event reports in the FDA FAERS database where SOTATERCEPT-CSRK was used for Pulmonary arterial hypertension.

Most Reported Side Effects for SOTATERCEPT-CSRK

Side Effect Reports % Deaths Hosp.
Headache 187 11.8% 2 54
Epistaxis 151 9.5% 0 38
Diarrhoea 132 8.3% 2 44
Haemoglobin increased 100 6.3% 3 18
Dyspnoea 93 5.9% 5 65
Fatigue 93 5.9% 2 38
No adverse event 93 5.9% 0 0
Dizziness 90 5.7% 2 37
Nausea 88 5.6% 1 32
Dyspnoea exertional 61 3.9% 1 23
Pericardial effusion 60 3.8% 0 26
Platelet count decreased 49 3.1% 4 14
Rash 49 3.1% 1 9
Pneumonia 47 3.0% 2 45
Product dose omission issue 47 3.0% 0 6

Other Indications for SOTATERCEPT-CSRK

Product used for unknown indication (360) Pulmonary hypertension (37)

Other Drugs Used for Pulmonary arterial hypertension

TREPROSTINIL (72,609) MACITENTAN (29,246) AMBRISENTAN (27,852) BOSENTAN (12,387) SELEXIPAG (11,861) RIOCIGUAT (9,158) EPOPROSTENOL (8,508) TADALAFIL (7,679) SILDENAFIL (5,239) ILOPROST (2,828)

Related Pages

SOTATERCEPT-CSRK Full Profile All Pulmonary arterial hypertension Drugs SOTATERCEPT-CSRK Demographics SOTATERCEPT-CSRK Timeline